Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 158

    1.

    Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.

    Arutchelvam V, Heise T, Dellweg S, Elbroend B, Minns I, Home PD.

    Diabet Med. 2009 Oct;26(10):1027-32.PMID: 19900235 [PubMed - in process]Related articles

    2.

    Endothelial Progenitor Cells in Subclinical Hypothyroidism: The Effect of Thyroid Hormone Replacement Therapy.

    Shakoor SK, Aldibbiat A, Ingoe LE, Campbell SC, Sibal L, Shaw J, Home PD, Razvi S, Weaver JU.

    J Clin Endocrinol Metab. 2009 Nov 6. [Epub ahead of print]PMID: 19897678 [PubMed - as supplied by publisher]Related articles

    3.

    Combined randomised controlled trial experience of malignancies in studies using insulin glargine.

    Home PD, Lagarenne P.

    Diabetologia. 2009 Sep 15. [Epub ahead of print]PMID: 19756478 [PubMed - as supplied by publisher]Related articlesFree article

    4.

    Management of type 2 diabetes: NICE guidelines.

    Sibal L, Home PD.

    Clin Med. 2009 Aug;9(4):353-7. No abstract available. PMID: 19728510 [PubMed - indexed for MEDLINE]Related articles

    5.

    An exploratory study of the effect of using high-mix biphasic insulin aspart in people with type 2 diabetes.

    Dashora U, Ashwell SG, Home PD.

    Diabetes Obes Metab. 2009 Jul;11(7):680-7.PMID: 19527481 [PubMed - in process]Related articles

    6.

    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

    Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

    Lancet. 2009 Jun 20;373(9681):2125-35. Epub 2009 Jun 6.PMID: 19501900 [PubMed - indexed for MEDLINE]Related articles

    7.

    A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

    Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, Home PD.

    Cardiovasc Diabetol. 2009 Jun 1;8:27.PMID: 19486510 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.

    Sibal L, Aldibbiat A, Agarwal SC, Mitchell G, Oates C, Razvi S, Weaver JU, Shaw JA, Home PD.

    Diabetologia. 2009 Aug;52(8):1464-73. Epub 2009 May 30.PMID: 19484217 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

    Diabetes Care. 2009 Jul;32(7):1170-6. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944. PMID: 19389820 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Surgery and the prevention of limb loss in diabetes.

    Home PD.

    Br J Surg. 2009 Mar;96(3):227-8. No abstract available. PMID: 19224511 [PubMed - indexed for MEDLINE]Related articles

    11.

    HbA(1c): the case for using estimated average glucose (eAG).

    Home PD.

    Diabet Med. 2008 Aug;25(8):895-8. No abstract available. PMID: 18959600 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of the UKPDS--an overview.

    Home PD.

    Diabet Med. 2008 Aug;25 Suppl 2:2-8. Review.PMID: 18717971 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

    Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A, Jones NP, Gomis R, Home PD; RECORD Study Group.

    Cardiovasc Diabetol. 2008 Apr 24;7:10.PMID: 18435852 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes.

    Ashwell SG, Bradley C, Stephens JW, Witthaus E, Home PD.

    Diabetes Care. 2008 Jun;31(6):1112-7. Epub 2008 Mar 13.PMID: 18339977 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.

    Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G.

    Diabetologia. 2008 Mar;51(3):408-16. Epub 2008 Jan 16.PMID: 18204830 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H.

    Evid Based Med. 2007 Dec;12(6):170. No abstract available. PMID: 18063730 [PubMed]Related articles

    17.

    Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.

    Home PD, Pacini G.

    Diabetes Obes Metab. 2008 Sep;10(9):699-718. Epub 2007 Sep 6. Review.PMID: 17825080 [PubMed - indexed for MEDLINE]Related articles

    18.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rosiglitazone RECORD study: glucose control outcomes at 18 months.

    Home PD, Jones NP, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Komajda M, Curtis P; RECORD Study Group.

    Diabet Med. 2007 Jun;24(6):626-34.PMID: 17517066 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.

    Davis MD, Beck RW, Home PD, Sandow J, Ferris FL.

    Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):240-3. Erratum in: Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):473. PMID: 17479440 [PubMed - indexed for MEDLINE]Related articles

    21.

    A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

    Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW.

    Diabet Med. 2007 Jun;24(6):618-25. Epub 2007 Apr 2.PMID: 17403121 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.

    Dashora UK, Sibal L, Ashwell SG, Home PD.

    Diabet Med. 2007 Apr;24(4):344-9. Epub 2007 Jan 12.PMID: 17298589 [PubMed - indexed for MEDLINE]Related articles

    24.

    The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.

    Gallagher A, Butler TJ, Home PD.

    Diabetes Res Clin Pract. 2007 Jun;76(3):327-34. Epub 2006 Nov 7.PMID: 17092597 [PubMed - indexed for MEDLINE]Related articles

    25.

    Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.

    Ashwell SG, Gebbie J, Home PD.

    Diabet Med. 2006 Aug;23(8):879-86.PMID: 16911626 [PubMed - indexed for MEDLINE]Related articles

    26.

    A model of long-term metabolic progression of type 2 diabetes mellitus for evaluating treatment strategies.

    Bagust A, Evans M, Beale S, Home PD, Perry AS, Stewart M.

    Pharmacoeconomics. 2006;24 Suppl 1:5-19. Review.PMID: 16800159 [PubMed - indexed for MEDLINE]Related articles

    27.

    Cost-effectiveness of CSII.

    Home PD.

    Diabet Med. 2006 Jun;23(6):707; author reply 707-8. No abstract available. PMID: 16759317 [PubMed - indexed for MEDLINE]Related articles

    28.

    Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes.

    Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, Shutler SD, Stephens JW, Home PD.

    Diabet Med. 2006 Mar;23(3):285-92.PMID: 16492212 [PubMed - indexed for MEDLINE]Related articles

    29.

    Identifying the impact of diabetes research.

    Hanney SR, Home PD, Frame I, Grant J, Green P, Buxton MJ.

    Diabet Med. 2006 Feb;23(2):176-84.PMID: 16433716 [PubMed - indexed for MEDLINE]Related articles

    30.

    Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.

    Ashwell SG, Gebbie J, Home PD.

    Diabet Med. 2006 Jan;23(1):46-52.PMID: 16409565 [PubMed - indexed for MEDLINE]Related articles

    31.

    Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes.

    Home PD, Hallgren P, Usadel KH, Sane T, Faber J, Grill V, Friberg HH.

    Diabetes Res Clin Pract. 2006 Feb;71(2):131-9. Epub 2005 Jul 27.PMID: 16054266 [PubMed - indexed for MEDLINE]Related articles

    32.

    Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Dargie H, Komajda M, Gubb J, Biswas N, Jones NP.

    Diabetologia. 2005 Sep;48(9):1726-35. Epub 2005 Jul 16.PMID: 16025252 [PubMed - indexed for MEDLINE]Related articles

    33.

    A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.

    Home PD, Rosskamp R, Forjanic-Klapproth J, Dressler A; European Insulin Glargine Study Group.

    Diabetes Metab Res Rev. 2005 Nov-Dec;21(6):545-53.PMID: 16021649 [PubMed - indexed for MEDLINE]Related articles

    34.

    Guidelines for the treatment and management of new-onset diabetes after transplantation.

    Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M.

    Clin Transplant. 2005 Jun;19(3):291-8. Review.PMID: 15877787 [PubMed - indexed for MEDLINE]Related articles

    35.

    The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.

    Gallagher A, Home PD.

    Diabetes Res Clin Pract. 2005 Mar;67(3):196-203.PMID: 15713351 [PubMed - indexed for MEDLINE]Related articles

    36.

    Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications.

    Consoli A, Gomis R, Halimi S, Home PD, Mehnert H, Strojek K, Van Gaal LF.

    Diabetes Metab. 2004 Dec;30(6):509-16. Review.PMID: 15671920 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes.

    Boehm BO, Vaz JA, Brøndsted L, Home PD.

    Eur J Intern Med. 2004 Dec;15(8):496-502.PMID: 15668084 [PubMed - as supplied by publisher]Related articles

    38.

    A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes.

    DeVries JH, Lindholm A, Jacobsen JL, Heine RJ, Home PD; Tri-Continental Insulin Aspart Study Group.

    Diabet Med. 2003 Apr;20(4):312-8.PMID: 12675646 [PubMed - indexed for MEDLINE]Related articles

    39.

    An overview of insulin glargine.

    Home PD, Ashwell SG.

    Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S57-63. Review.PMID: 12324987 [PubMed - indexed for MEDLINE]Related articles

    40.

    Standardization of glycated haemoglobin.

    Marshall SM, Home PD, Manley SE, Barth JH, John WG.

    Diabet Med. 2002 May;19(5):429. No abstract available. PMID: 12027933 [PubMed - indexed for MEDLINE]Related articles

    41.

    Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients.

    Boehm BO, Home PD, Behrend C, Kamp NM, Lindholm A.

    Diabet Med. 2002 May;19(5):393-9. Erratum in: Diabet Med. 2002 Sep;19(9):797.. PMID: 12027927 [PubMed - indexed for MEDLINE]Related articles

    42.

    Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes.

    Lindholm A, Jensen LB, Home PD, Raskin P, Boehm BO, Råstam J.

    Diabetes Care. 2002 May;25(5):876-82.PMID: 11978684 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Therapeutic targets in the management of Type 1 diabetes.

    Home PD.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18 Suppl 1:S7-13. Review.PMID: 11921424 [PubMed - indexed for MEDLINE]Related articles

    44.

    Standardization of glycated haemoglobin.

    Marshall SM, Home PD, Manley SE, Barth JH, John WG.

    Ann Clin Biochem. 2002 Jan;39(Pt 1):78-9. No abstract available. PMID: 11853199 [PubMed - indexed for MEDLINE]Related articles

    45.

    Insulin glargine: the first clinically useful extended-action insulin analogue.

    Ashwell SG, Home PD.

    Expert Opin Pharmacother. 2001 Nov;2(11):1891-902. Review.PMID: 11825324 [PubMed - indexed for MEDLINE]Related articles

    46.

    Postprandial hyperglycaemia: mechanisms and importance.

    Home PD.

    Diabetes Obes Metab. 2000 Mar;2 Suppl 1:S7-11. Review. No abstract available. PMID: 11225761 [PubMed - indexed for MEDLINE]Related articles

    47.

    Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

    Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group.

    Diabet Med. 2000 Nov;17(11):762-70.PMID: 11131100 [PubMed - indexed for MEDLINE]Related articles

    48.

    Rapid-acting insulin analogues: when randomized clinical trial results do not help.

    Home PD.

    Diabet Med. 2000 Sep;17 Suppl 2:6-8. No abstract available. PMID: 11048825 [PubMed - indexed for MEDLINE]Related articles

    49.

    Rapid-acting insulin secretagogues: a clinical need?

    Home PD.

    Exp Clin Endocrinol Diabetes. 1999;107 Suppl 4:S115-9. Review.PMID: 10522834 [PubMed - indexed for MEDLINE]Related articles

    50.

    Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers.

    Home PD, Barriocanal L, Lindholm A.

    Eur J Clin Pharmacol. 1999 May;55(3):199-203.PMID: 10379635 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...